These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3337904)

  • 41. Chromosomal instability in acute myelocytic leukemia and myelodysplastic syndrome patients among atomic bomb survivors.
    Nakanishi M; Tanaka K; Shintani T; Takahashi T; Kamada N
    J Radiat Res; 1999 Jun; 40(2):159-67. PubMed ID: 10494147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurring chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Semin Hematol; 1990 Apr; 27(2):122-36. PubMed ID: 2190318
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chromosome aberrations in malignant blood diseases].
    Engel E; McKee LC; Engel-de Montmollin M
    Union Med Can; 1968 Jul; 97(7):901-6. PubMed ID: 5709532
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cytogenetic study of exudates secondary to hematologic processes].
    Bello MJ; Rey JA; Moreno S; Martínez Castro P; Benítez J
    Sangre (Barc); 1988 Jun; 33(3):165-70. PubMed ID: 3175812
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
    Cadman EC; Capizzi RL; Bertino JR
    Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Philadelphia chromosome-positive acute leukemia: morphologic and clinical correlations.
    Helenglass G; Testa JR; Schiffer CA
    Am J Hematol; 1987 Jul; 25(3):311-24. PubMed ID: 3474891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of cytogenetics in neoplastic diseases.
    Sandberg AA
    Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary leukemia with a translocation (8;21)?
    Davies SV; Murray JA; Bowser-Riley SM
    Cancer Genet Cytogenet; 1988 Apr; 31(2):271-4. PubMed ID: 3162399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities.
    Lai JL; Fenaux P; Zandecki M; Nelken B; Huart JJ; Deminatti M
    Ann Genet; 1989; 32(1):26-32. PubMed ID: 2751244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytogenetic study of acute leukemia].
    Fraisse J; Frocrain-Herchkovitch C; Turc-Carel C
    Sem Hop; 1983 May; 59(19):1471-3. PubMed ID: 6310764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytogenetic findings in the dysmyelopoietic syndrome.
    Kardon N; Schulman P; Degnan TJ; Budman DR; Davis J; Vinciguerra V
    Cancer; 1982 Dec; 50(12):2834-8. PubMed ID: 6958354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of chromosome arm 3p in hematologic malignancies.
    Johansson B; Billström R; Kristoffersson U; Akerman M; Garwicz S; Ahlgren T; Malm C; Mitelman F
    Leukemia; 1997 Aug; 11(8):1207-13. PubMed ID: 9264371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
    Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Van den Berghe H
    Cancer Genet Cytogenet; 1988 Dec; 36(2):165-72. PubMed ID: 3203304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow monosomy 7: hematologic and clinical manifestations in childhood and adolescence.
    Hutter JJ; Hecht F; Kaiser-McCaw B; Hays T; Baranko P; Cohen J; Durie B
    Hematol Oncol; 1984; 2(1):5-12. PubMed ID: 6588021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosomal abnormalities and their specificity in human neoplasms: an assessment of recent observations by banding techniques.
    Mark J
    Adv Cancer Res; 1977; 24():165-222. PubMed ID: 322458
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis.
    Gertz MA; Kyle RA
    Arch Intern Med; 1990 Mar; 150(3):629-33. PubMed ID: 2310282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Significance of cytogenetic methods in the diagnosis and differential diagnosis of myeloproliferative diseases (review of the literature and personal data)].
    Fleĭshman EV; Volkova MA
    Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):53-8. PubMed ID: 4935743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.